New possible silver lining for pancreatic cancer therapy:Hydrogen sulfide and its donors

来源 :药学学报(英文版) | 被引量 : 0次 | 上传用户:zhanfeifan
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
As one of the most lethal diseases,pancreatic cancer shows a dismal overall prognosis and high resistance to most treatment modalities.Furthermore,pancreatic cancer escapes early detection dur-ing the curable period because early symptoms rarely emerge and specific markers for this disease have not been found.Although combinations of new drugs,multimodal therapies,and adjuvants prolong sur-vival,most patients still relapse after surgery and eventually die.Consequently,the search for more effec-tive treatments for pancreatic cancer is highly relevant and justified.As a newly re-discovered mediator of gasotransmission,hydrogen sulfide(H2S)undertakes essential functions,encompassing various signaling complexes that occupy key processes in human biology.Accumulating evidence indicates that H2S ex-hibits bimodal modulation of cancer development.Thus,endogenous or low levels of exogenous H2S are thought to promote cancer,whereas high doses of exogenous H2S suppress tumor proliferation.Simi-larly,inhibition of endogenous H2S production also suppresses tumor proliferation.Accordingly,H2S biosynthesis inhibitors and H2S supplementation(H2S donors)are two distinct strategies for the treatment of cancer.Unfortunately,modulation of endogenous H2S on pancreatic cancer has not been studied so far.However,H2S donors and their derivatives have been extensively studied as potential therapeutic agents for pancreatic cancer therapy by inhibiting cell proliferation,inducing apoptosis,arresting cell cycle,and suppressing invasion and migration through exploiting multiple signaling pathways.As far as we know,there is no review of the effects of H2S donors on pancreatic cancer.Based on these concerns,the ther-apeutic effects of some H2S donors and NO-H2S dual donors on pancreatic cancer were summarized in this paper.Exogenous H2S donors may be promising compounds for pancreatic cancer treatment.
其他文献
New approaches to cancer immunotherapy have been developed,showing the ability to harness the immune system to treat and eliminate cancer.For many solid tumors,therapy with checkpoint inhibitors has shown promise.For hematologic malignancies,adoptive and
The management of the central nervous system(CNS)disorders is challenging,due to the need of drugs to cross the blood-brain barrier(BBB)and reach the brain.Among the various strategies that have been studied to circumvent this challenge,the use of the int
This special APSB issue marks the beginning of a series of celebratory events for the 10-year anniversary of the journal.It was June 2011,when the first issue of the journal was published.It has been an exciting decade for the growth of the journal,which
期刊
Liver is the most common metastatic site for colorectal cancer(CRC),there is no satisfied approach to treat CRC liver metastasis(CRCLM).Here,we investigated the role of a polycomb protein BMI-1 in CRCLM.Immunohistochemical analysis showed that BMI-1 expre
Anoctamin 1 (ANO1) or TMEM16A gene encodes a member of Ca2+ activated C1-channels(CaCCs) that are critical for physiological functions,such as epithelial secretion,smooth muscle contrac-tion and sensory signal transduction.The attraction and interest in A
Nature has endowed gaseous molecules such as O2,CO2,CO,NO,H2S,and N2 with critical and diverse roles in sustaining life,from supplying energy needed to power life and building blocks for life\'s physical structure to mediating and coordinating cellular
The recent discovery of activator compounds binding to an allosteric site on the NAD+-dependent protein lysine deacetylase,sirtuin 6(SIRT6)has attracted interest and presents a pharmaceu-tical target for aging-related and cancer diseases.However,the mecha
HYD-PEP06,an endostatin-modified polypeptide,has been shown to produce effective anti-colorectal carcinoma effects through inhibiting epithelial--mesenchymal transition (EMT).However,whether HYD-PEP06 has similar suppressive effect on hepatocellular carci
Over the past decade,traditional Chinese medicine (TCM) has widely embraced systems biology and its various data integration approaches to promote its modernization.Thus,integrative pharmacology-based traditional Chinese medicine (TCMIP) was proposed as a
IF1 (ATPIF1) is a nuclear DNA-encoded mitochondrial protein whose activity is inhibition of the F1Fo-ATP synthase to control ATP production.IF1 activity remains unknown in the regulation of GLP-1 activity.In this study,IF1 was examined in the diet-induced